Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,678 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Correction to "Optimization Efforts for Identification of Novel Highly Potent Keap1-Nrf2 Protein-Protein Interaction Inhibitors".
Otake K, Hara Y, Ubukata M, Inoue M, Nagahashi N, Motoda D, Ogawa N, Hantani Y, Hantani R, Adachi T, Nomura A, Yamaguchi K, Maekawa M, Mamada H, Motomura T, Sato M, Harada K. Otake K, et al. Among authors: ogawa n. J Med Chem. 2024 Sep 12;67(17):15925. doi: 10.1021/acs.jmedchem.4c01985. Epub 2024 Sep 2. J Med Chem. 2024. PMID: 39219436 No abstract available.
Methyl and Fluorine Effects in Novel Orally Bioavailable Keap1-Nrf2 PPI Inhibitor.
Otake K, Ubukata M, Nagahashi N, Ogawa N, Hantani Y, Hantani R, Adachi T, Nomura A, Yamaguchi K, Maekawa M, Mamada H, Motomura T, Sato M, Harada K. Otake K, et al. Among authors: ogawa n. ACS Med Chem Lett. 2023 Apr 7;14(5):658-665. doi: 10.1021/acsmedchemlett.3c00067. eCollection 2023 May 11. ACS Med Chem Lett. 2023. PMID: 37197451 Free PMC article.
Discovery of Selective Transforming Growth Factor β Type II Receptor Inhibitors as Antifibrosis Agents.
Miwa S, Yokota M, Ueyama Y, Maeda K, Ogoshi Y, Seki N, Ogawa N, Nishihata J, Nomura A, Adachi T, Kitao Y, Nozawa K, Ishikawa T, Ukaji Y, Shiozaki M. Miwa S, et al. Among authors: ogawa n. ACS Med Chem Lett. 2021 Apr 21;12(5):745-751. doi: 10.1021/acsmedchemlett.0c00679. eCollection 2021 May 13. ACS Med Chem Lett. 2021. PMID: 34055221 Free PMC article.
Discovery of a potent and short-acting oral calcilytic with a pulsatile secretion of parathyroid hormone.
Shinagawa Y, Inoue T, Katsushima T, Kiguchi T, Ikenogami T, Ogawa N, Fukuda K, Hirata K, Harada K, Takagi M, Nakagawa T, Kimura S, Matsuo Y, Maekawa M, Hayashi M, Soejima Y, Takahashi M, Shindo M, Hashimoto H. Shinagawa Y, et al. Among authors: ogawa n. ACS Med Chem Lett. 2010 Dec 29;2(3):238-42. doi: 10.1021/ml100268k. eCollection 2011 Mar 10. ACS Med Chem Lett. 2010. PMID: 24900301 Free PMC article.
Prevalence of vertebral fractures at death.
Ogawa N, Yamamoto M, Kobayashi R, Kawamura A, Matsumoto A, Otani H, Kanasaki K. Ogawa N, et al. J Bone Miner Metab. 2025 Jan 13. doi: 10.1007/s00774-025-01577-z. Online ahead of print. J Bone Miner Metab. 2025. PMID: 39806228
Oral applause sign in progressive supranuclear palsy.
Katsuse K, Kakinuma K, Kawakami N, Ota S, Kawamura A, Ogawa N, Iseki C, Hamada M, Toda T, Kanno S, Matsuda M, Suzuki K. Katsuse K, et al. Among authors: ogawa n. Cortex. 2024 Dec 27:S0010-9452(24)00353-8. doi: 10.1016/j.cortex.2024.11.021. Online ahead of print. Cortex. 2024. PMID: 39753504 Free article.
1,678 results